OncoSec Medical Incorporated

The biopharmaceutical industry cheered Third Harmonic Bio ’s sizeable initial public offering in mid-September but the IPO market in the US has gone quiet since then as broader stock indices – includ

Initial public offerings for US biopharmaceutical companies generally slowed as 2021 drew to a close and biotechnology stock valuations continued to fall below broader stock indices. Nevertheless, thr

Inovio’s VGX-3100 Inovio Pharmaceuticals, Inc. plans to file for regulatory approval of its DNA vaccine candidate VGX-3100 for the treatment of cervical dysplasia caused by HPV 18 and 16 before the

Zydus Cadila ’s application to the Indian regulator for an accelerated nod or emergency use authorization (EUA) for its COVID-19 vaccine takes the world a step closer to the first plasmid DNA vaccine